• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥曲肽、饮食和停止透析治疗早产儿乳糜性腹水。

Resolution of chyloperitoneum in a preterm with octreotide, diet and cessation of dialysis.

机构信息

Division of Nephrology, Department of Pediatrics, Dokuz Eylul University, 35340 Inciralti, Balçova, Izmir, Turkey.

出版信息

Pediatr Nephrol. 2010 Feb;25(2):363-6. doi: 10.1007/s00467-009-1340-5. Epub 2009 Nov 10.

DOI:10.1007/s00467-009-1340-5
PMID:19902268
Abstract

The diagnosis of chyloperitoneum (CP) is based on the presence of high levels of triglycerides (TGs) in the dialysate. It is a rare complication of peritoneal dialysis (PD) and even rarer in neonates. We report here the case of CP in a 1700-g male baby delivered at the 30th gestational week due to posterior urethral valve and associated oligohydramnios. On postnatal day 2, the serum creatinine (Scr) was 1.6 mg/dL, and he was anuric. PD was instituted via a Tenckhoff catheter. At the end of the second week, after the initiation of enteral feeding, the ultrafiltrate became cloudy, with a leukocyte count of 900/mm(3). A treatment regimen consisting of intraperitoneal vancomycin and ceftazidime was then started. Five days later, the fluid became milky, with a TG level of 251 mg/dL. The patient was then placed on a diet based on medium-chain triglycerides and octreotide (1 microg/kg/h; increasing up to 2 microg/kg/h over 15 days). Although the TG and leukocyte levels decreased, the milky appearance persisted. PD was stopped for 2 days when the Scr decreased to 1.7 mg/dL. When it was resumed, the fluid was totally clear, with a TG level of 7 mg/dL. The infant was discharged with a nightly intermittent peritoneal dialysis program and has had no recurrence. In summary, we report a preterm infant who developed CP during PD and recovered following treatment that included diet modification, octreotide, and temporary discontinuation of the PD.

摘要

乳糜性腹水(CP)的诊断基于透析液中甘油三酯(TGs)水平升高。它是腹膜透析(PD)的一种罕见并发症,在新生儿中更为罕见。我们在此报告一例 30 孕周因后尿道瓣膜和相关羊水过少而分娩的 1700 克男性婴儿 CP 病例。生后第 2 天,血清肌酐(Scr)为 1.6mg/dL,无尿。通过 Tenckhoff 导管进行 PD。在第二周结束时,在开始肠内喂养后,超滤液变得混浊,白细胞计数为 900/mm(3)。然后开始使用腹腔内万古霉素和头孢他啶进行治疗。5 天后,液体变得乳白色,TG 水平为 251mg/dL。然后,患者开始采用中链甘油三酯和奥曲肽(1μg/kg/h;15 天内增加至 2μg/kg/h)饮食治疗。尽管 TG 和白细胞计数降低,但乳白色外观仍持续存在。当 Scr 降至 1.7mg/dL 时,PD 停止了 2 天。当恢复 PD 时,液体完全清澈,TG 水平为 7mg/dL。婴儿出院时采用夜间间歇性腹膜透析方案,且无复发。总之,我们报告了一例早产儿在 PD 期间发生 CP,并在包括饮食调整、奥曲肽和暂时停止 PD 在内的治疗后恢复。

相似文献

1
Resolution of chyloperitoneum in a preterm with octreotide, diet and cessation of dialysis.奥曲肽、饮食和停止透析治疗早产儿乳糜性腹水。
Pediatr Nephrol. 2010 Feb;25(2):363-6. doi: 10.1007/s00467-009-1340-5. Epub 2009 Nov 10.
2
Recurrent chyloperitoneum: a rare complication of peritoneal dialysis.复发性乳糜性腹水:腹膜透析的一种罕见并发症。
Pediatr Nephrol. 2008 Apr;23(4):671-4. doi: 10.1007/s00467-007-0674-0. Epub 2007 Dec 19.
3
Use of Propranolol in the Treatment of Chylous Effusions in Infants.普萘洛尔在婴儿乳糜性胸腔积液治疗中的应用。
Pediatrics. 2021 Jul;148(1). doi: 10.1542/peds.2020-049699. Epub 2021 Jun 29.
4
Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum.奥曲肽疗法:医源性乳糜腹治疗的新视野。
Arch Dis Child. 2001 Sep;85(3):234-5. doi: 10.1136/adc.85.3.234.
5
Chyloperitoneum in a peritoneal dialysis patient.一名腹膜透析患者出现乳糜性腹水。
Am J Kidney Dis. 2001 Sep;38(3):E12. doi: 10.1053/ajkd.2001.26916.
6
Octreotide therapy for chylous ascites in a chronic dialysis patient.奥曲肽治疗慢性透析患者的乳糜性腹水
Nephrology (Carlton). 2005 Aug;10(4):344-7. doi: 10.1111/j.1440-1797.2005.00427.x.
7
The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis.奥曲肽治疗肝硬化后乳糜性腹水的疗效
Dig Dis Sci. 2009 Aug;54(8):1783-8. doi: 10.1007/s10620-008-0566-6. Epub 2008 Dec 3.
8
Successful management of congenital chylous ascites in a premature infant using somatostatin analogue.采用生长抑素类似物成功治疗一例早产儿先天性乳糜性腹水。
Indian J Pediatr. 2011 Mar;78(3):345-7. doi: 10.1007/s12098-010-0256-1. Epub 2010 Oct 16.
9
Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report.奥曲肽用于肝硬化乳糜性腹水的门诊治疗:一例报告
Dig Liver Dis. 2006 Feb;38(2):138-42. doi: 10.1016/j.dld.2005.05.013. Epub 2006 Jan 4.
10
Therapeutic management of neonatal chylous ascites: report of a case and review of the literature.新生儿乳糜性腹水的治疗管理:病例报告及文献复习。
Acta Paediatr. 2010 Sep;99(9):1307-10. doi: 10.1111/j.1651-2227.2010.01818.x.

引用本文的文献

1
Chyloperitoneum in a toddler on peritoneal dialysis.一名接受腹膜透析的幼儿出现乳糜性腹水。
Pediatr Nephrol. 2025 May;40(5):1599-1602. doi: 10.1007/s00467-024-06597-x. Epub 2024 Dec 2.
2
Milky appearance of peritoneal fluid in a neonate on peritoneal dialysis due to end-stage renal disease: Answers.终末期肾病导致新生儿腹膜透析时腹腔积液呈乳糜样外观:答案。
Pediatr Nephrol. 2018 Jan;33(1):73-76. doi: 10.1007/s00467-017-3633-4. Epub 2017 Mar 10.
3
Safety of octreotide in hospitalized infants.奥曲肽在住院婴儿中的安全性。

本文引用的文献

1
Chylous ascites: an unusual complication of peritoneal dialysis. A case report and literature review.乳糜性腹水:腹膜透析的一种罕见并发症。病例报告及文献综述
Perit Dial Int. 2008 May-Jun;28(3):229-31.
2
Recurrent chyloperitoneum: a rare complication of peritoneal dialysis.复发性乳糜性腹水:腹膜透析的一种罕见并发症。
Pediatr Nephrol. 2008 Apr;23(4):671-4. doi: 10.1007/s00467-007-0674-0. Epub 2007 Dec 19.
3
Postoperative chylous ascites in a neonate treated successfully with octreotide: bile sludge and cholestasis.奥曲肽成功治疗新生儿术后乳糜性腹水:胆泥与胆汁淤积
Early Hum Dev. 2015 Jul;91(7):387-92. doi: 10.1016/j.earlhumdev.2015.04.008. Epub 2015 May 15.
Am J Perinatol. 2005 Nov;22(8):401-4. doi: 10.1055/s-2005-872588.
4
Octreotide therapy for chylous ascites in a chronic dialysis patient.奥曲肽治疗慢性透析患者的乳糜性腹水
Nephrology (Carlton). 2005 Aug;10(4):344-7. doi: 10.1111/j.1440-1797.2005.00427.x.
5
Chyloperitoneum in a peritoneal dialysis patient.一名腹膜透析患者出现乳糜性腹水。
Am J Kidney Dis. 2001 Sep;38(3):E12. doi: 10.1053/ajkd.2001.26916.
6
Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum.奥曲肽疗法:医源性乳糜腹治疗的新视野。
Arch Dis Child. 2001 Sep;85(3):234-5. doi: 10.1136/adc.85.3.234.
7
Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis.接受腹膜透析的儿科患者腹膜炎治疗的共识指南。
Perit Dial Int. 2000 Nov-Dec;20(6):610-24.
8
Chylous ascites complicating neonatal peritoneal dialysis.乳糜性腹水并发新生儿腹膜透析
Pediatr Nephrol. 1995 Dec;9(6):753-5. doi: 10.1007/BF00868734.
9
Chylous ascites: an unexpected complication that resembles peritonitis.
ANNA J. 1995 Apr;22(2):157-9.
10
Chylous ascites in a patient treated with intermittent peritoneal dialysis.一名接受间歇性腹膜透析治疗的患者出现乳糜性腹水。
Artif Organs. 1984 Aug;8(3):358-60.